Rating Agencies

Share recommendations

Made with ❤ von BGFL
#BGFLapp * beta

Valuable background information and well-founded assessments of individual stocks are provided by the studies of the research houses. On this page, Boersengefluester.de (BGFL) provides an integrated overview of all analyst recommendations that come in via the EQS Group newsfeed - enriched with current stock charts as well as meaningful key figure tables and investor information from BGFL. Tip: You are also welcome to use the EQS newsfeed, which we have also enhanced with all the latest company news from our coverage universe.

All Issuers BankM AG GBC AG First Berlin Equity Research GmbH
19.07.2024 04:16PM
Study issued by First Berlin Equity Research GmbH

PNE AG (von First Berlin Equity Research GmbH): Buy

Buy
Company Name: PNE AG ISIN: DE000A0JBPG2   Reason for the research: Update Recommendation: Buy from: 19.07.2024 Target price: 21,00 Euro Target price on sight of: 12 Monate Last rating change: 02.02.2023: Hochstufung von Hinzufügen auf Kaufen Analyst: Dr. Karsten von Blumenthal First Berlin Equity Research hat ein Research U [ … ]
Read More
Original Research
DE000A0JBPG2 A0JBPG
PNE
18.07.2024 11:12AM
Study issued by First Berlin Equity Research GmbH

Knaus Tabbert AG (von First Berlin Equity Research GmbH): Kaufen

Kaufen
First Berlin Equity Research hat ein Research Update zu Knaus Tabbert AG (ISIN: DE000A2YN504) veröffentlicht. Analyst Ellis Acklin bestätigt seine BUY-Empfehlung und senkt das Kursziel von EUR 86,00 auf EUR 69,00. Zusammenfassung: KTA senkte ihre Prognose für die EBITDA-Marge 2024 um 100 Basispunkte auf 7% - 8% (zuvor: 8% - 9%).  [ … ]
Read More
Original Research
DE000A2YN504 A2YN50
Knaus Tabbert
16.07.2024 03:17PM
Study issued by First Berlin Equity Research GmbH

ad pepper media International N.V. (von First Berlin Equity Research GmbH): Buy

Buy
First Berlin Equity Research hat ein Research Update zu ad pepper media International N.V. (ISIN: NL0000238145) veröffentlicht. Analyst Dr. Karsten von Blumenthal bestätigt seine BUY-Empfehlung und bestätigt sein Kursziel von EUR 2,90. Zusammenfassung: Trotz geringerer Q2-Umsätze (-3% J/J) verbesserte sich das EBITDA deutlic [ … ]
Read More
Original Research
NL0000238145 940883
ad pepper media
15.07.2024 03:56PM
Study issued by First Berlin Equity Research GmbH

Knaus Tabbert AG (von First Berlin Equity Research GmbH): Kaufen

Kaufen
First Berlin Equity Research hat ein Research Update zu Knaus Tabbert AG (ISIN: DE000A2YN504) veröffentlicht. Analyst Ellis Acklin bestätigt seine BUY-Empfehlung und bestätigt sein Kursziel von EUR 86,00. Zusammenfassung: Zu Beginn der Q2-Berichtsaison veröffentlichen wir eine Reihe von sommerlichen Wegweisern und Überl [ … ]
Read More
Original Research
DE000A2YN504 A2YN50
Knaus Tabbert
11.07.2024 05:31PM
Study issued by First Berlin Equity Research GmbH

ParTec AG (von First Berlin Equity Research GmbH): Buy

Buy
First Berlin Equity Research has published a research update on ParTec AG (ISIN: DE000A3E5A34). Analyst Simon Scholes reiterated his BUY rating and decreased the price target from EUR 220.00 to EUR 170.00. Abstract: 2023 sales rose 165% y/y to €95.7m (2022: €36.1m) and were close to our forecast of €96.8m. The gap between 2023 EB [ … ]
Read More
Original Research
DE000A3E5A34 A3E5A3
ParTec
03.07.2024 03:42PM
Study issued by First Berlin Equity Research GmbH

Energiekontor AG (von First Berlin Equity Research GmbH): Buy

Buy
First Berlin Equity Research hat ein Research Update zu Energiekontor AG (ISIN: DE0005313506) veröffentlicht. Analyst Dr. Karsten von Blumenthal bestätigt seine BUY-Empfehlung und bestätigt sein Kursziel von EUR 126,00. Zusammenfassung: In den letzten Wochen ist der Aktienkurs von Energiekontor um fast 20% gesunken, da sich das S [ … ]
Read More
Original Research
DE0005313506 531350
Energiekontor
24.06.2024 11:01AM
Study issued by First Berlin Equity Research GmbH

APONTIS PHARMA AG (von First Berlin Equity Research GmbH): Buy

Buy
First Berlin Equity Research on 24/06/2024 initiated coverage on APONTIS PHARMA AG (ISIN: DE000A3CMGM5/ Bloomberg: APPH GR). Analyst Christian Orquera placed a BUY rating on the stock, with a EUR 17.00 price target. Abstract: Apontis Pharma AG (Apontis) is a leading specialty pharmaceutical company focusing on the development and marketing of a [ … ]
Read More
Original Research
DE000A3CMGM5 A3CMGM
Apontis Pharma
24.06.2024 09:16AM
Study issued by First Berlin Equity Research GmbH

Verve Group SE (von First Berlin Equity Research GmbH): Kaufen

Kaufen
First Berlin Equity Research hat ein Research Update zu Verve Group SE (ISIN: SE0018538068) veröffentlicht. Analyst Ellis Acklin bestätigt seine BUY-Empfehlung und erhöht das Kursziel von EUR 4,10 auf EUR 4,90. Zusammenfassung: Die kürzlich umbenannte Verve Group SE hat mit der strategischen Übernahme der Jun Group, ein [ … ]
Read More
Original Research
SE0018538068 A3D3A1
Verve Group
13.06.2024 10:41AM
Study issued by First Berlin Equity Research GmbH

Formycon AG (von First Berlin Equity Research GmbH): Buy

Buy
First Berlin Equity Research has published a research update on Formycon AG (ISIN: DE000A1EWVY8). Analyst Simon Scholes reiterated his BUY rating and decreased the price target from EUR 105.00 to EUR 80.00. Abstract: The Formycon share price has fallen by more than 40% since the beginning of 2023, mainly because of lower than expected royalty i [ … ]
Read More
Original Research
DE000A1EWVY8 A1EWVY
Formycon
12.06.2024 02:46PM
Study issued by First Berlin Equity Research GmbH

MPH Health Care AG (von First Berlin Equity Research GmbH): Kaufen

Kaufen
First Berlin Equity Research hat ein Research Update zu MPH Health Care AG (ISIN: DE000A289V03) veröffentlicht. Analyst Ellis Acklin bestätigt seine BUY-Empfehlung und erhöht das Kursziel von EUR 81,00 auf EUR 113,00. Zusammenfassung: Der Nettoinventarwert (NAV) für Q1 stieg um etwa 34% J/J auf €252 Mio., blieb aber sei [ … ]
Read More
Original Research
DE000A289V03 A289V0
MPH Health Care

Advertising is an important revenue channel for us. But we understand, that sometimes it becomes annoying. If you want to reduce the number of shown ADs just simply login to your useraccount and manage the settings from there. As registered user you get even more benefits.
We have summarised companies with a market capitalisation of more than EUR 1 billion that are not included in any index under X-Caps.
Dataselect Tool Family
          Rating Agencies          
          Qualitätsjournalismus · Made in Germany © 2024          
boersengefluester.de · #BGFL · © 2024
The news manufactory
Good luck with all your investments

Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.

Quick Links

About us
Testimonials
Referenzen
Media Kid
Privacy
Terms of use
Imprint

Network

Baha
EQS News
Finanznachrichten
Server 24

Partner

BankM
Cometis
Cross Alliance
Fino Digital
GBC
Monetga

Contact

Idea & concept: 3R Technologies   
boersengefluester.de GmbH Copyright © 2024 by Gereon Kruse #BGFL